↓ Skip to main content

An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
Published in
Orphanet Journal of Rare Diseases, March 2022
DOI 10.1186/s13023-022-02260-6
Pubmed ID
Authors

Leanne Marie Ward, Alexandra Chambers, Emine Mechichi, Durhane Wong-Rieger, Craig Campbell

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Researcher 3 13%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Unspecified 1 4%
Other 1 4%
Unknown 11 46%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 8%
Social Sciences 2 8%
Unspecified 1 4%
Other 1 4%
Unknown 12 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2022.
All research outputs
#6,979,415
of 23,509,982 outputs
Outputs from Orphanet Journal of Rare Diseases
#977
of 2,704 outputs
Outputs of similar age
#140,280
of 441,596 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#39
of 141 outputs
Altmetric has tracked 23,509,982 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 2,704 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,596 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.